Chugai Pharmaceutical Co Ltd
OTC:CHGCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Chugai Pharmaceutical Co Ltd
OTC:CHGCY
|
JP |
|
Hennessy Capital Investment Corp VI
OTC:HCVI
|
US |
|
G
|
Goldn Futures Mineral Corp
CNSX:FUTR
|
CA |
|
D
|
DeFi Development Corp
XMUN:F6S0
|
US |
Wall Street
Price Targets
CHGCY Price Targets Summary
Chugai Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
CHGCY
is 31.5 USD
with a low forecast of 21.5 USD and a high forecast of 46.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CHGCY's stock price target?
Price Target
31.5
USD
According to Wall Street analysts, the average 1-year price target for
CHGCY
is 31.5 USD
with a low forecast of 21.5 USD and a high forecast of 46.45 USD.
What is Chugai Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
10%
For the last 14 years the
compound annual growth rate for
Chugai Pharmaceutical Co Ltd's revenue is
9%.
The projected
CAGR
for the next 3 years is
10%.
What is Chugai Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-15%
For the last 14 years the
compound annual growth rate for
Chugai Pharmaceutical Co Ltd's operating income is
18%.
The projected
CAGR
for the next 12 years is
-15%.
What is Chugai Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
15%
For the last 14 years the
compound annual growth rate for
Chugai Pharmaceutical Co Ltd's net income is
20%.
The projected
CAGR
for the next 3 years is
15%.
